There was a tendency of anti-MSP1-19 antibodies to be associated with higher risk of febrile malaria (HR: 1.40, 95%CI: 1.09–1.80, p = 0.008), but overall the correlation between antibodies and increased risk of malaria was reduced by adjusting for exposure and season. The gene discussed is ATAD1; the disease is malaria.